Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer

Radiotherapy and Oncology

Volumn 79, Issue 3, 2006, Pages 341-347

  Geinitz, Hans ^a   Zimmermann, Frank B ^a   Thamm, Reinhard ^a   Erber, Caroline ^a   Müller, Tobias ^a   Keller, Monika ^b   Busch, Raymonde ^c   Molls, Michael ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Conformal radiation therapy; Fecal continence; Prostate cancer; Quality of life; Rectal toxicity

Indexed keywords

ADULT; AGED; ANAL COMPLAINT; ARTICLE; COGNITION; DIARRHEA; FECES INCONTINENCE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RECTUM DISEASE; TENESMUS;

AGED; AGED, 80 AND OVER; FECAL INCONTINENCE; GERMANY; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, CONFORMAL; REFERENCE VALUES;

EID: 33746216870     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.05.004     Document Type: Article

References (37)

1. Potosky A.L., Davis W.D., Hoffman R.M., et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 96 18 (2004) 1358-1367
2. Wei J.T., Dunn R.L., Sandler H.M., et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20 (2002) 557-566
3. Bacon C.G., Giovannucci E., Testa M., et al. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 166 (2001) 1804-1810
4. Shrader-Bogen C.L., Kjellberg J.L., McPherson C.P., et al. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer 79 10 (1997) 1977-1986
5. Litwin M.S., Hays R.D., Fink A., et al. Quality-of-life outcomes in men treated for localized prostate cancer. J Am Med Assoc 273 2 (1995) 129-135
6. Lilleby W., Fossa S.D., Waehre H.R., et al. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 43 4 (1999) 735-743
7. Teshima T., Hanks G.E., Hanlon A.L., et al. Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity. Int J Radiat Oncol Biol Phys 39 1 (1997) 77-83
8. Geinitz H., Zimmermann F., Thamm R., et al. 3-D conformal radiation therapy for prostate cancer in elderly patients. Radiother Oncol 76 1 (2005) 27-34
9. Nichol A., Chung P., Lockwood P., et al. A phase II study of localized prostate cancer treated to 75.5 Gy with 3D conformal radiotherapy. Radiother Oncol 76 (2005) 27-34
10. Valdagni R., Italia C., Montanaro P., et al. Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hypofractionated conformal radiotherapy. Radiother Oncol 75 (2005) 74-82
11. Goldner G., Zimmermann F., Feldmann H.J., et al. 3-D conformal radiotherapy of localized prostate cancer: A subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects. Radiother Oncol 78 (2006) 41-46
12. Fokdal L., Honore H., Hoyer M., et al. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. Radiother Oncol 74 (2005) 203-210
13. Rancati T., Fiorino C., Gagliardi G., et al. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101). Radiother Oncol 73 (2004) 21-32
14. Karlsdottir A., Jahannessen D.C., Muren L.P., et al. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiother Oncol 71 (2004) 43-53
15. Koper P.C., Jansen P., van Putten W., et al. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial. Radiother Oncol 73 (2004) 1-9
16. Christie D., Denham J., Steigler A., et al. Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation. Radiother Oncol 77 (2005) 117-125
17. Boersma L.J., van den B.M., Bruce A.M., et al. Bruce AM et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 1 (1998) 83-92
18. Hanlon A., Watkins Bruner D., Peter R., et al. Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population. Int J Radiat Oncol Biol Phys 49 (2001) 51-59
19. Widmark A., Fransson P., and Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 74 9 (1994) 2520-2532
20. Nguyen T.D., Pollack A., and Zagars G.K. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Urology 51 (1998) 991-997
21. Madalinska J.B., Essink-Bot M.L., de Koning H.J., et al. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol 19 6 (2001) 1619-1628
22. Hamilton A.S., Stanford J.L., Gilliland F.D., et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol 19 9 (2001) 2517-2526
23. Yeoh E.E., Botten R., Russo A., et al. Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys 47 4 (2000) 915-924
24. al-Abany M., Helgason A.R., Cronqvist A.-K.A., et al. Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum. Int J Radiat Oncol Biol Phys 61 (2005) 1035-1044
25. Vordermark D., Schwab M., Ness-Dourdoumas R., et al. Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate. Radiother Oncol 69 (2003) 209-214
26. Little D.J., Kuban D.A., Levy L.B., et al. Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study. Urology 62 (2003) 707-713
27. Geinitz H., Zimmermann F., Wedel E., et al. Biochemische Kontrolle nach konformaler, dreidimensionaler Strahlentherapie des Prostatakarzinoms. Strahlenther Onkol 178 (2002) 369-377
28. Jorge J.M., and Wexner S.D. Etiology and management of fecal incontinence. Dis Colon Rectum 36 (1993) 77-97
29. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 5 (1993) 365-376
30. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997; 37(5):1035-1041.
31. Schwarz R., and Hinz A. Reference data for the quality of life questionnnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37 (2001) 1345-1351
32. Fransson P., Damber J.E., Tomic R., et al. Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma. Cancer 92 (2001) 3111-3119
33. Janda M., Gerstner N., Obermair A., et al. Quality of life changes during conformal radiation therapy for prostate carcinoma. Cancer 89 6 (2000) 1322-1328
34. Beard C.J., Propert K.J., Rieker P.P., et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol 15 1 (1997) 223-229
35. Johnstone P.A., Gray C., and Powell C.R. Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up. Int J Radiat Oncol Biol Phys 46 4 (2000) 833-838
36. Crook J., Esche B., and Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual functioning: the patients perspective. Urology 47 (1996) 387-394
37. Litwin M.S. Health related quality of life in older men without prostate cancer. J Urol 161 (1999) 1180-1184